Clinical Trials

Toll-Free: 866.320.4573

Call Us Toll Free:

866.223.2273 x1234

DNA Variations in the Gene in Young Patients With Wilms` Tumor

Study:

The Incidence, Inheritance, and Prognostic Significance of Polymorphisms in the RASSF1A Gene in Children With Wilms Tumors

Rationale:

Studying samples of blood from patients with cancer in the laboratory may help doctors learn more about changes that may occur in DNA and identify biomarkers related to cancer.

Purpose:

This laboratory study is looking at DNA variations in the RASSF1A gene in young patients with Wilms` tumor.

Study Status: Active, not recruiting

Recruiting:
n/a

Condition Intervention Phase
Kidney Cancer Genetic: molecular genetic technique
Genetic: polymerase chain reaction
Genetic: polymorphism analysis
N/A

Verified by Children`s Oncology Group November, 2004

Sponsored by: Children`s Oncology Group
Information provided by: National Cancer Institute (NCI)
ClinicalTrials.gov identifier: NCT00088803

Study Type: Interventional

Study Design: N/A

Cleveland Clinic Taussig Cancer Center
Cleveland, Ohio 44195
United States

Gail E. Tomlinson, MD, PhD., Study Chair

This information is abridged to display results relevant only to Cleveland Clinic. To see complete record visit ClinicalTrials.gov
  Information obtained from ClinicalTrials.gov on
Link to the current ClinicalTrials.gov record.

Cleveland Clinic Mobile Site